PolyPeptide Group AG Logo

PolyPeptide Group AG

ISIN: CH1110760852 | Ticker: PPGN | LEI: 5067007JCKTPOX4G9758
Sector: Health CareSub-Industry: Health Care Supplies
Country: Switzerland

About PolyPeptide Group AG

Company Description

PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with around 1,100 employees at the end of 2021, its diversity brings breadth, depth of knowledge and experience to the group.

PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing.

Served area

Worldwide

Headcount

1,100

Headquarters

Dammstrasse 19, 6300 Zug – Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
11.04.24 None Non-Executive member Buy CHF 75,000.00
11.04.24 None Non-Executive member Buy CHF 72,000.00
11.04.24 None Non-Executive member Buy CHF 50,000.00
11.04.24 None Non-Executive member Buy CHF 35,000.00
10.11.23 None Executive member Buy CHF 51,250.00
11.10.23 None Executive member Buy CHF 2,876,348.62
10.10.23 None Executive member Buy CHF 371,202.96
26.04.22 None Non-Executive member Buy CHF 90,000.00
26.04.22 None Non-Executive member Buy CHF 70,000.00
26.04.22 None Non-Executive member Buy CHF 50,000.00

Capital markets information

ISIN

CH1110760852

LEI

5067007JCKTPOX4G9758

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.